Peel Hunt Reconfirms a “Hold” Rating on ITE Group PLC (LON:ITE) and GBX 150.00 Target; Freestone Capital Holdings Trimmed Teva Pharmaceutical Inds LTD (TEVA) Holding

July 13, 2017 - By Hazel Jackson

Peel Hunt currently has a GBX 150.00 target price on the 434.84M GBP market cap company or -5.36% downside potential. In analysts note shared with investors on 13 July, ITE Group PLC (LON:ITE) stock had its “Hold” Rating restate by equity analysts at Peel Hunt.

Freestone Capital Holdings Llc decreased Teva Pharmaceutical Inds Ltd (TEVA) stake by 55.74% reported in 2016Q4 SEC filing. Freestone Capital Holdings Llc sold 53,945 shares as Teva Pharmaceutical Inds Ltd (TEVA)’s stock declined 15.11%. The Freestone Capital Holdings Llc holds 42,827 shares with $1.55M value, down from 96,772 last quarter. Teva Pharmaceutical Inds Ltd now has $32.49 billion valuation. The stock increased 3.62% or $1.12 during the last trading session, reaching $32.09. About 10,220 shares traded. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 41.70% since July 13, 2016 and is downtrending. It has underperformed by 58.40% the S&P500.

Freestone Capital Holdings Llc increased Microsoft Corp (NASDAQ:MSFT) stake by 5,391 shares to 107,867 valued at $6.70 million in 2016Q4. It also upped Cohen & Steers Mlp Inc & Enr (MIE) stake by 55,367 shares and now owns 154,067 shares. Philip Morris Intl Inc (NYSE:PM) was raised too.

Among 25 analysts covering Teva Pharma (NYSE:TEVA), 13 have Buy rating, 0 Sell and 12 Hold. Therefore 52% are positive. Teva Pharma had 65 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Neutral” rating by JP Morgan given on Friday, January 20. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has “Neutral” rating given on Wednesday, November 16 by Mizuho. Credit Suisse initiated Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on Wednesday, May 4 with “Neutral” rating. The firm has “Outperform” rating given on Tuesday, July 21 by Leerink Swann. Nomura initiated Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on Tuesday, September 29 with “Neutral” rating. The stock has “Buy” rating by Bank of America on Tuesday, January 31. The firm has “Equal Weight” rating by Barclays Capital given on Tuesday, January 31. Mizuho upgraded the stock to “Buy” rating in Friday, June 16 report. The company was downgraded on Friday, February 10 by Mizuho. As per Monday, October 31, the company rating was upgraded by Credit Suisse.

Among 5 analysts covering ITE Group PLC (LON:ITE), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. ITE Group PLC has GBX 230 highest and GBX 145 lowest target. GBX 167.80’s average target is 3.74% above currents GBX 161.75 stock price. ITE Group PLC had 50 analyst reports since October 1, 2015 according to SRatingsIntel. The stock of ITE Group plc (LON:ITE) has “Buy” rating given on Friday, November 6 by Numis Securities. The firm has “Hold” rating given on Tuesday, November 29 by Canaccord Genuity. The rating was maintained by Investec on Thursday, January 5 with “Add”. Numis Securities maintained the shares of ITE in report on Tuesday, November 29 with “Buy” rating. The company was maintained on Tuesday, May 17 by Peel Hunt. Peel Hunt maintained the stock with “Hold” rating in Tuesday, May 16 report. Numis Securities maintained it with “Buy” rating and GBX 215 target in Wednesday, December 2 report. Canaccord Genuity maintained ITE Group plc (LON:ITE) on Monday, October 3 with “Hold” rating. The company was maintained on Thursday, December 3 by Investec. Numis Securities maintained the stock with “Buy” rating in Thursday, January 26 report.